IWMvsXPH
iShares Russell 2000 ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | XPH | |
|---|---|---|
| Expense ratio | 0.19% | 0.35% |
| Assets | $76.6B | $528M |
| Net flow, 1 month | −$4.3B | +$50M |
| Net flow, 1 year | −$3.3B | +$263M |
| Return, YTD | +10.9% | +16.7% |
| Return, 1 year | — | — |
| Avg daily volume | 23.5M | 208K |
| Holdings | 1970 | 61 |
| Listed | May 22, 2000 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS